Skip to main content
825 search results for:

Bosutinib 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Bosutinib | News

    Bosutinib/imatinib

    Lack of efficacy and Knuckle hyperpigmentation
  2. 01-04-2024 | Bosutinib | News

    Bosutinib

    Pericardial effusion and pleural effusion
  3. 01-03-2024 | Bosutinib | News

    Bosutinib

    Heart failure and grade 3 diarrhoea
  4. 03-04-2024 | Bosutinib | Online First

    Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study

    In the field of chronic myeloid leukemia (CML), new strategies are needed to increase the rate of successful treatment discontinuations, a crucial goal in this disease. Anti-PD-L1 checkpoint inhibitors are a promising therapeutic approach in CML …

  5. 07-12-2023 | Bosutinib | ReviewPaper

    Bosutinib: Pediatric First Approval

    Bosutinib (BOSULIF®), an orally administered BCR–ABL tyrosine kinase inhibitor (TKI) developed by Pfizer Inc., is well established in the EU and the USA as a treatment for adults with newly diagnosed (ND) chronic phase (CP) Philadelphia …

  6. 01-11-2023 | Dasatinib | News

    Bosutinib/dasatinib

    Hydrothorax, cytopenia and enteropathy: case report
  7. 01-10-2023 | Bosutinib | News

    Bosutinib

    Hepatic toxicity: case report
  8. 01-07-2023 | Bosutinib | News

    Bosutinib/imatinib

    Chylothorax and gastrointestinal intolerance: case report
  9. 01-05-2023 | Myalgie | News

    Bosutinib

    QTc prolongation, myalgias and skin toxicity: 3 case reports
  10. 01-04-2023 | Pleural Effusion | News

    Bosutinib/dasatinib/nilotinib

    Pleural effusion, skin eruptions and diarrhoea: case report
  11. Open Access 18-08-2023 | Bosutinib | OriginalPaper

    Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study

    The approved dose of bosutinib in chronic phase CML is 400 mg QD in first-line and 500 mg QD in later-line treatment. However, given that gastrointestinal (GI) toxicity typically occurs early after treatment initiation, physicians often tend to …

  12. 01-11-2022 | Pleural Effusion | News

    Bosutinib/imatinib

    Pneumonitis and lack of efficacy: case report
  13. 01-10-2022 | Eosinophilia | News

    Bosutinib

    Late-onset hepatocellular liver injury and eosinophilia: 5 case reports
  14. 01-10-2022 | Pleural Effusion | News

    Bosutinib/dasatinib

    Bilateral pleural effusion: case report
  15. 01-09-2023 | Bosutinib | News

    Bosutinib-related risk of interstitial lung disease

  16. 01-08-2022 | Tyrosine Kinase Inhibitors | News

    Bosutinib

    Various toxicities and lack of efficacy following off-label use: 5 case reports
  17. 01-06-2022 | Hypertension | News

    Bosutinib/dasatinib

    Pulmonary arterial hypertension: case report
  18. 01-05-2022 | Pleural Effusion | News

    Bosutinib/dasatinib

    Pulmonary arterial hypertension and pleural effusion: case report
  19. 01-03-2022 | Bosutinib | News

    Bosutinib/dasatinib/imatinib

    Allergy: case report
  20. 01-12-2021 | Portal Vein Thrombosis | News

    Bosutinib

    Liver injury: case report

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.